Literature DB >> 9055640

Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization.

P U Devi1.   

Abstract

Study of antitumor and radiosensitizing properties of W. somnifera (Ashwagandha), a well known medicinal plant, have yielded encouraging results. The alcoholic extract of the dried roots of the plant as well as the active component withaferin A isolated from the extract showed significant antitumor and radiosensitizing effects in experimental tumors in vivo, without any noticeable systemic toxicity. Withaferin A gave a sensitizer enhancement ratio of 1.5 for in vitro cell killing of V79 Chinese hamster cells at a non toxic concentration of approximately 2 microM. The mechanism of action of this compound is not known. The studies so far indicate that W. somnifera could prove to be a good natural source of a potent and relatively safe radiosensitizer/chemotherapeutic agent. Further studies are needed to explore the clinical potential of this plant for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9055640

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  21 in total

1.  Comparing the cytotoxic potential of Withania somnifera water and methanol extracts.

Authors:  Etheresia Pretorius; Hester Magdalena Oberholzer; Petrus Johannes Becker
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-05-07

2.  Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A.

Authors:  Xuan Zhang; Abbas K Samadi; Katherine F Roby; Barbara Timmermann; Mark S Cohen
Journal:  Gynecol Oncol       Date:  2011-12-03       Impact factor: 5.482

Review 3.  Withaferin A and its potential role in glioblastoma (GBM).

Authors:  Jasdeep Dhami; Edwin Chang; Sanjiv S Gambhir
Journal:  J Neurooncol       Date:  2016-11-11       Impact factor: 4.130

4.  Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields.

Authors:  Edwin Chang; Christoph Pohling; Nooshin Beygui; Chirag B Patel; Jarrett Rosenberg; Dong Ho Ha; Sanjiv S Gambhir
Journal:  J Neurooncol       Date:  2017-07-05       Impact factor: 4.130

5.  Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies.

Authors:  Guy Lahat; Quan-Sheng Zhu; Kai-Lieh Huang; Suizhao Wang; Svetlana Bolshakov; Jeffery Liu; Keila Torres; Robert R Langley; Alexander J Lazar; Mien Chie Hung; Dina Lev
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

6.  Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols.

Authors:  Wipob Suttana; Samlee Mankhetkorn; Wilart Poompimon; Ajay Palagani; Sergey Zhokhov; Sarah Gerlo; Guy Haegeman; Wim Vanden Berghe
Journal:  Mol Cancer       Date:  2010-05-03       Impact factor: 27.401

7.  Practical Application of "About Herbs" Website: Herbs and Dietary Supplement Use in Oncology Settings.

Authors:  Yen-Nien Hou; Gary Deng; Jun J Mao
Journal:  Cancer J       Date:  2019 Sep/Oct       Impact factor: 3.360

8.  Studies on leaf spot disease of Withania somnifera and its impact on secondary metabolites.

Authors:  Pratap Kumar Pati; Monica Sharma; Raj Kumar Salar; Ashutosh Sharma; A P Gupta; B Singh
Journal:  Indian J Microbiol       Date:  2009-01-08       Impact factor: 2.461

9.  Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid-'Ashwagandha' in Prostate Cancer Cells.

Authors:  Ravikumar Aalinkeel; Zihua Hu; Bindukumar B Nair; Donald E Sykes; Jessica L Reynolds; Supriya D Mahajan; Stanley A Schwartz
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-10       Impact factor: 2.629

10.  Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo.

Authors:  Huanjie Yang; Ying Wang; Vino T Cheryan; Wenjuan Wu; Cindy Qiuzhi Cui; Lisa A Polin; Harvey I Pass; Q Ping Dou; Arun K Rishi; Anil Wali
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.